| Addressing extreme propensity scores in estimating counterfactual survival functions via the overlap weights C Cheng, F Li, LE Thomas, F Li American journal of epidemiology 191 (6), 1140-1151, 2022 | 36 | 2022 |
| Estimating the natural indirect effect and the mediation proportion via the product method C Cheng, D Spiegelman, F Li BMC medical research methodology 21, 1-20, 2021 | 32 | 2021 |
| Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials BS Blette, J Moutchia, N Al-Naamani, CE Ventetuolo, C Cheng, ... The Lancet Respiratory Medicine 11 (10), 873-882, 2023 | 20 | 2023 |
| A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes FP Wilson, Y Yamamoto, M Martin, C Coronel-Moreno, F Li, C Cheng, ... Nature communications 14 (1), 2826, 2023 | 16 | 2023 |
| Surrogate residuals for discrete choice models C Cheng, R Wang, H Zhang Journal of Computational and Graphical Statistics 30 (1), 67-77, 2021 | 9 | 2021 |
| Design and implementation of a culturally-tailored randomized pilot trial: Puerto Rican optimized Mediterranean-like diet J Mattei, CB Díaz-Alvarez, C Alfonso, HJ O’Neill, CF Ríos-Bedoya, ... Current Developments in Nutrition 7 (1), 100022, 2023 | 6 | 2023 |
| Multiply robust estimation for causal survival analysis with treatment noncompliance C Cheng, Y Guo, B Liu, L Wruck, F Li arXiv preprint arXiv:2305.13443, 2023 | 5 | 2023 |
| Is the product method more efficient than the difference method for assessing mediation? C Cheng, D Spiegelman, F Li American Journal of Epidemiology 192 (1), 84-92, 2023 | 5 | 2023 |
| Mediation analysis in the presence of continuous exposure measurement error C Cheng, D Spiegelman, F Li Statistics in Medicine 42 (11), 1669-1686, 2023 | 3 | 2023 |
| The impact of a community health worker intervention on uptake of antenatal care: a cluster-randomized pragmatic trial in Dar es Salaam M Regan, C Cheng, E Mboggo, E Larson, IA Lema, L Magesa, L Machumi, ... Health Policy and Planning 38 (3), 279-288, 2023 | 3 | 2023 |
| Semiparametric causal mediation analysis in cluster-randomized experiments C Cheng, F Li arXiv preprint arXiv:2404.18256, 2024 | 2 | 2024 |
| Doubly robust estimation and sensitivity analysis for marginal structural quantile models C Cheng, L Hu, F Li Biometrics, 2022 | 2 | 2022 |
| Statistical methods for analysis of combined categorical biomarker data from multiple studies C Cheng, M Wang The annals of applied statistics 14 (3), 1146, 2020 | 2 | 2020 |
| A repeated measures approach to pooled and calibrated biomarker data A Sloan, C Cheng, B Rosner, RG Ziegler, SA Smith‐Warner, M Wang Biometrics 79 (2), 1485-1495, 2023 | 1 | 2023 |
| Identification and multiply robust estimation in causal mediation analysis across principal strata C Cheng, F Li arXiv preprint arXiv:2304.10025, 2023 | 1 | 2023 |
| Statistical methods for analysis of combined biomarker data from multiple nested case–control studies C Cheng, A Sloan, M Wang Statistical methods in medical research 30 (8), 1944-1959, 2021 | 1 | 2021 |
| Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness-Implementation Studies MA Owen, GM Curran, JD Smith, Y Tedla, C Cheng, D Spiegelman arXiv preprint arXiv:2411.08929, 2024 | | 2024 |
| Doubly robust estimation and sensitivity analysis with outcomes truncated by death in multi-arm clinical trials J Tong, C Cheng, G Tong, MO Harhay, F Li arXiv preprint arXiv:2410.07483, 2024 | | 2024 |
| Inverting estimating equations for causal inference on quantiles C Cheng, F Li Biometrika, 2024 | | 2024 |
| Multiply robust estimation of principal causal effects with noncompliance and survival outcomes C Cheng, Y Guo, B Liu, L Wruck, F Li, F Li Clinical Trials, 17407745241251773, 2024 | | 2024 |
